Drugmakers Look to Supreme Court for Clarification, Shields
By Mari Serebrov
Thursday, September 19, 2013
With the Supreme Court beginning its next session later this month, drugmakers are looking to the justices for guidance in shareholder, whistleblower and patent infringement cases while seeking protection from punitive damages and some civil suits.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.